135 related articles for article (PubMed ID: 36702320)
21. Neuregulin-1 beta 1 is implicated in pathogenesis of multiple sclerosis.
Kataria H; Hart CG; Alizadeh A; Cossoy M; Kaushik DK; Bernstein CN; Marrie RA; Yong VW; Karimi-Abdolrezaee S
Brain; 2021 Feb; 144(1):162-185. PubMed ID: 33313801
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Mitochondrial Dysfunction in Experimental Autoimmune Encephalomyelitis (EAE) Models of Multiple Sclerosis.
Ng X; Sadeghian M; Heales S; Hargreaves IP
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600882
[TBL] [Abstract][Full Text] [Related]
23. Icariin ameliorates the progression of experimental autoimmune encephalomyelitis by down-regulating the major inflammatory signal pathways in a mouse relapse-remission model of multiple sclerosis.
Cong H; Zhang M; Chang H; Du L; Zhang X; Yin L
Eur J Pharmacol; 2020 Oct; 885():173523. PubMed ID: 32871176
[TBL] [Abstract][Full Text] [Related]
24. Silencing of the RNA-binding protein HuR attenuates hyperalgesia and motor disability in experimental autoimmune encephalomyelitis.
Sanna MD; Quattrone A; Galeotti N
Neuropharmacology; 2017 Sep; 123():116-125. PubMed ID: 28599923
[TBL] [Abstract][Full Text] [Related]
25. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.
Bjartmar C; Wujek JR; Trapp BD
J Neurol Sci; 2003 Feb; 206(2):165-71. PubMed ID: 12559505
[TBL] [Abstract][Full Text] [Related]
26. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
27. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
Bing SJ; Ha D; Hwang I; Park E; Ahn G; Song JY; Jee Y
Am J Chin Med; 2016; 44(6):1099-1110. PubMed ID: 27627913
[TBL] [Abstract][Full Text] [Related]
28. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
29. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
30. Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis.
Kuo PC; Weng WT; Scofield BA; Paraiso HC; Brown DA; Wang PY; Yu IC; Yen JH
J Neuroinflammation; 2020 Apr; 17(1):138. PubMed ID: 32349768
[TBL] [Abstract][Full Text] [Related]
31. Pathological findings in rats with experimental allergic encephalomyelitis.
Dong M; Liu R; Guo L; Li C; Tan G
APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
[TBL] [Abstract][Full Text] [Related]
32. Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis.
Tanabe S; Fujita Y; Ikuma K; Yamashita T
Cell Death Dis; 2018 Oct; 9(11):1061. PubMed ID: 30333477
[TBL] [Abstract][Full Text] [Related]
33. Characterization of brain lesions in a mouse model of progressive multiple sclerosis.
Levy H; Assaf Y; Frenkel D
Exp Neurol; 2010 Nov; 226(1):148-58. PubMed ID: 20736006
[TBL] [Abstract][Full Text] [Related]
34. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
[TBL] [Abstract][Full Text] [Related]
35. Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis.
Soellner IA; Rabe J; Mauri V; Kaufmann J; Addicks K; Kuerten S
Clin Immunol; 2013 Dec; 149(3):519-29. PubMed ID: 24239839
[TBL] [Abstract][Full Text] [Related]
36. Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis.
Honorat JA; Kinoshita M; Okuno T; Takata K; Koda T; Tada S; Shirakura T; Fujimura H; Mochizuki H; Sakoda S; Nakatsuji Y
PLoS One; 2013; 8(8):e71329. PubMed ID: 23951137
[TBL] [Abstract][Full Text] [Related]
37. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Black JA; Liu S; Hains BC; Saab CY; Waxman SG
Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
[TBL] [Abstract][Full Text] [Related]
38. Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.
Soulika AM; Lee E; McCauley E; Miers L; Bannerman P; Pleasure D
J Neurosci; 2009 Nov; 29(47):14965-79. PubMed ID: 19940192
[TBL] [Abstract][Full Text] [Related]
39. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
[TBL] [Abstract][Full Text] [Related]
40. Cuprizone-Dependent De/Remyelination Responses and Functional Correlates in Mouse Strains Adopted to Model Relapsing, Chronic and Progressive Experimental Autoimmune Encephalomyelitis.
Buonvicino D; Ranieri G; Chiarugi A
Neurotox Res; 2021 Jun; 39(3):658-666. PubMed ID: 33475965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
